Live Music
Archive
Librivox
Free Audio
Metropolitan Museum
Cleveland
Museum of Art
Internet
Arcade
Console Living Room
Open Library
American
Libraries
TV News
Understanding
9/11Keynote: Open Source Pharma
Video Item Preview
Share or Embed This Item
- Usage
- Attribution 4.0 International
- Topics
- lca, lca2018, #linux.conf.au#linux#foss#opensource, MatthewTodd
- Language
- English
- Item Size
- 611.6M
Matthew Todd
http://lca2018.linux.org.au/schedule/presentation/218/
The open sharing of research is being increasingly recognised as a driver of innovation in biomedical research. Many funding agencies now mandate the open sharing of project-related data, and most pharmaceutical companies are engaged in substantial "open innovation” programs.
Inspired by radical initiatives in software development, we have demonstrated the logical extension of such ideas to "open source drug discovery" in which all data and ideas are shared in real time, anyone can participate and no patent protection is sought.
The pilot project with the World Health Organisation involved creating an improved version of the world's most widely used antiparasitic drug, praziquantel. More recently we created a consortium committed to secret-free drug discovery, Open Source Malaria, to which scientists have contributed from the private and public sectors, ranging from academics to school students. Related efforts are exploring potential new treatments for other major diseases such as tuberculosis and mycetoma, again with all work taking place in the public domain and disclosed in real time.
It is still the case that no drug has ever reached the market using this approach. The lack of any precedence means there is hesitation from funders to invest on a large scale. In part to address this we have recently argued for the expansion of such an approach to full-scale drug development as a competing model for the traditional pharmaceutical industry, Open Source Pharma. This idea will be outlined, as will the major scientific and software needs of this growing community.
This talk was given at Linux.conf.au 2018 (LCA2018) which was held on 22-26 January 2018 in Sydney Australia.
linux.conf.au is a conference about the Linux operating system, and all aspects of the thriving ecosystem of Free and Open Source Software that has grown up around it. Run since 1999, in a different Australian or New Zealand city each year, by a team of local volunteers, LCA invites more than 500 people to learn from the people who shape the future of Open Source. For more information on the conference see https://linux.conf.au/
#linux.conf.au #linux #foss #opensource
http://lca2018.linux.org.au/schedule/presentation/218/
The open sharing of research is being increasingly recognised as a driver of innovation in biomedical research. Many funding agencies now mandate the open sharing of project-related data, and most pharmaceutical companies are engaged in substantial "open innovation” programs.
Inspired by radical initiatives in software development, we have demonstrated the logical extension of such ideas to "open source drug discovery" in which all data and ideas are shared in real time, anyone can participate and no patent protection is sought.
The pilot project with the World Health Organisation involved creating an improved version of the world's most widely used antiparasitic drug, praziquantel. More recently we created a consortium committed to secret-free drug discovery, Open Source Malaria, to which scientists have contributed from the private and public sectors, ranging from academics to school students. Related efforts are exploring potential new treatments for other major diseases such as tuberculosis and mycetoma, again with all work taking place in the public domain and disclosed in real time.
It is still the case that no drug has ever reached the market using this approach. The lack of any precedence means there is hesitation from funders to invest on a large scale. In part to address this we have recently argued for the expansion of such an approach to full-scale drug development as a competing model for the traditional pharmaceutical industry, Open Source Pharma. This idea will be outlined, as will the major scientific and software needs of this growing community.
This talk was given at Linux.conf.au 2018 (LCA2018) which was held on 22-26 January 2018 in Sydney Australia.
linux.conf.au is a conference about the Linux operating system, and all aspects of the thriving ecosystem of Free and Open Source Software that has grown up around it. Run since 1999, in a different Australian or New Zealand city each year, by a team of local volunteers, LCA invites more than 500 people to learn from the people who shape the future of Open Source. For more information on the conference see https://linux.conf.au/
#linux.conf.au #linux #foss #opensource
Reviews
268 Views
Uploaded by CarlFK on
